Myriad Genetics Q4 Adj. EPS $0.04 Beats $(0.01) Estimate, Sales $209.800M Beat $207.366M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.01) by 366.67 percent. This is a 33.33 percent increase over earnings of $0.03 per share from
Myriad Genetics (NASDAQ:MYGN) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.01) by 366.67 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $209.800 million which beat the analyst consensus estimate of $207.366 million by 1.17 percent. This is a 0.38 percent decrease over sales of $210.600 million the same period last year.